Global Single-Domain Heavy Chain Antibody Market Growth (Status and Outlook) 2026-2032
The global Single-Domain Heavy Chain Antibody market size is predicted to grow from US$ 1096 million in 2025 to US$ 3374 million in 2032; it is expected to grow at a CAGR of 17.5% from 2026 to 2032.
Single-Domain Heavy Chain Antibody refers to a small antibody molecule in which a single variable domain can recognize and bind to an antigen. In industry usage, it is more commonly described as Single-Domain Antibody, VHH Antibody, or sdAb, covering camelid-derived VHH antibodies, shark-derived VNAR antibodies, and engineered human VH single-domain antibodies. Compared with conventional full-length IgG antibodies, these molecules are smaller, structurally simpler, and generally more stable, with good tissue penetration and strong engineering flexibility. They can be used in therapeutic biologics, diagnostic reagents, research antibodies, molecular imaging, cell therapy binding domains, and bispecific or multispecific antibody development. Key upstream inputs include antigen proteins or peptides, immunized animal resources, phage display libraries, yeast display libraries, synthetic antibody libraries, expression vectors, host cells, culture media, chromatography resins, conjugation reagents, and protein purification consumables. Major downstream customers include pharmaceutical companies, biotechnology companies, diagnostic companies, research service providers, universities, research institutes, and hospital laboratories. The global industry gross margin in 2025 is estimated at approximately 55%?75%.
The single-domain heavy chain antibody market is still in a stage of continuous platform validation and accelerating commercialization, with lower maturity than the conventional monoclonal antibody market but higher innovation activity. VHH, VNAR, and engineered human VH antibodies are gaining application momentum due to their small molecular size, good stability, engineering flexibility, and stronger tissue penetration. They are increasingly used in therapeutic biologics, diagnostic reagents, research antibodies, molecular imaging, and cell therapy engineering. Current market participants include innovative drug developers with proprietary platforms and clinical pipelines, as well as CROs and reagent companies providing antibody discovery, screening, humanization, affinity maturation, and protein expression services. The industry remains both platform-driven and project-driven.
From the demand side, therapeutic applications represent the highest long-term value area, especially in tumor immunology, immune-mediated inflammatory diseases, rare diseases, infectious diseases, and central nervous system delivery. Compared with conventional antibodies, single-domain antibodies are well suited for bispecific, multispecific, multivalent, and fusion protein formats, and can also serve as targeting domains for CAR-T, TCR-T, and other cell therapy products. At the same time, research and diagnostic applications provide a more stable demand base. Single-domain antibodies are well adapted for immunoassays, tissue staining, structural biology, live-cell imaging, and protein localization studies, supporting commercial demand before broader therapeutic commercialization.
Future development will focus on fully human platforms, multispecific design, half-life extension, AI-assisted screening, and high-throughput antibody library construction. The small size of single-domain antibodies is both an advantage and a limitation, as it can lead to faster in vivo clearance. As a result, albumin binding, Fc fusion, multivalent formatting, and PEGylation will remain important half-life extension strategies. With the integration of AI protein design, deep sequencing, synthetic antibody libraries, phage display, and yeast display technologies, discovery efficiency and developability assessment are expected to improve. Companies with strong capabilities in difficult-target screening, multi-format antibody engineering, CMC scale-up, and clinical translation will be better positioned in high-value therapeutic programs.
The main barriers include long clinical validation cycles, intellectual property constraints, immunogenicity control, manufacturing scale-up, and increasing service-level competition. Some VHH and VNAR molecules originate from non-human species, requiring sufficient humanization and immunogenicity assessment before therapeutic development. The short half-life associated with small molecular size also requires additional engineering, increasing R&D complexity. Meanwhile, as more CROs, research reagent suppliers, and platform companies enter VHH and sdAb discovery services, early-stage service pricing pressure may intensify. Overall, single-domain heavy chain antibodies are unlikely to simply replace conventional monoclonal antibodies, but they will continue to expand in differentiated scenarios such as difficult targets, multispecific formats, tissue penetration, imaging diagnostics, and cell therapy engineering.
LPI (LP Information)' newest research report, the ?Single-Domain Heavy Chain Antibody Industry Forecast? looks at past sales and reviews total world Single-Domain Heavy Chain Antibody sales in 2025, providing a comprehensive analysis by region and market sector of projected Single-Domain Heavy Chain Antibody sales for 2026 through 2032. With Single-Domain Heavy Chain Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Single-Domain Heavy Chain Antibody industry.
This Insight Report provides a comprehensive analysis of the global Single-Domain Heavy Chain Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Single-Domain Heavy Chain Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Single-Domain Heavy Chain Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Single-Domain Heavy Chain Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Single-Domain Heavy Chain Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of Single-Domain Heavy Chain Antibody market by product type, application, key players and key regions and countries.
Segmentation by Type:
Single-Domain Heavy Chain Antibody refers to a small antibody molecule in which a single variable domain can recognize and bind to an antigen. In industry usage, it is more commonly described as Single-Domain Antibody, VHH Antibody, or sdAb, covering camelid-derived VHH antibodies, shark-derived VNAR antibodies, and engineered human VH single-domain antibodies. Compared with conventional full-length IgG antibodies, these molecules are smaller, structurally simpler, and generally more stable, with good tissue penetration and strong engineering flexibility. They can be used in therapeutic biologics, diagnostic reagents, research antibodies, molecular imaging, cell therapy binding domains, and bispecific or multispecific antibody development. Key upstream inputs include antigen proteins or peptides, immunized animal resources, phage display libraries, yeast display libraries, synthetic antibody libraries, expression vectors, host cells, culture media, chromatography resins, conjugation reagents, and protein purification consumables. Major downstream customers include pharmaceutical companies, biotechnology companies, diagnostic companies, research service providers, universities, research institutes, and hospital laboratories. The global industry gross margin in 2025 is estimated at approximately 55%?75%.
The single-domain heavy chain antibody market is still in a stage of continuous platform validation and accelerating commercialization, with lower maturity than the conventional monoclonal antibody market but higher innovation activity. VHH, VNAR, and engineered human VH antibodies are gaining application momentum due to their small molecular size, good stability, engineering flexibility, and stronger tissue penetration. They are increasingly used in therapeutic biologics, diagnostic reagents, research antibodies, molecular imaging, and cell therapy engineering. Current market participants include innovative drug developers with proprietary platforms and clinical pipelines, as well as CROs and reagent companies providing antibody discovery, screening, humanization, affinity maturation, and protein expression services. The industry remains both platform-driven and project-driven.
From the demand side, therapeutic applications represent the highest long-term value area, especially in tumor immunology, immune-mediated inflammatory diseases, rare diseases, infectious diseases, and central nervous system delivery. Compared with conventional antibodies, single-domain antibodies are well suited for bispecific, multispecific, multivalent, and fusion protein formats, and can also serve as targeting domains for CAR-T, TCR-T, and other cell therapy products. At the same time, research and diagnostic applications provide a more stable demand base. Single-domain antibodies are well adapted for immunoassays, tissue staining, structural biology, live-cell imaging, and protein localization studies, supporting commercial demand before broader therapeutic commercialization.
Future development will focus on fully human platforms, multispecific design, half-life extension, AI-assisted screening, and high-throughput antibody library construction. The small size of single-domain antibodies is both an advantage and a limitation, as it can lead to faster in vivo clearance. As a result, albumin binding, Fc fusion, multivalent formatting, and PEGylation will remain important half-life extension strategies. With the integration of AI protein design, deep sequencing, synthetic antibody libraries, phage display, and yeast display technologies, discovery efficiency and developability assessment are expected to improve. Companies with strong capabilities in difficult-target screening, multi-format antibody engineering, CMC scale-up, and clinical translation will be better positioned in high-value therapeutic programs.
The main barriers include long clinical validation cycles, intellectual property constraints, immunogenicity control, manufacturing scale-up, and increasing service-level competition. Some VHH and VNAR molecules originate from non-human species, requiring sufficient humanization and immunogenicity assessment before therapeutic development. The short half-life associated with small molecular size also requires additional engineering, increasing R&D complexity. Meanwhile, as more CROs, research reagent suppliers, and platform companies enter VHH and sdAb discovery services, early-stage service pricing pressure may intensify. Overall, single-domain heavy chain antibodies are unlikely to simply replace conventional monoclonal antibodies, but they will continue to expand in differentiated scenarios such as difficult targets, multispecific formats, tissue penetration, imaging diagnostics, and cell therapy engineering.
LPI (LP Information)' newest research report, the ?Single-Domain Heavy Chain Antibody Industry Forecast? looks at past sales and reviews total world Single-Domain Heavy Chain Antibody sales in 2025, providing a comprehensive analysis by region and market sector of projected Single-Domain Heavy Chain Antibody sales for 2026 through 2032. With Single-Domain Heavy Chain Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Single-Domain Heavy Chain Antibody industry.
This Insight Report provides a comprehensive analysis of the global Single-Domain Heavy Chain Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Single-Domain Heavy Chain Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Single-Domain Heavy Chain Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Single-Domain Heavy Chain Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Single-Domain Heavy Chain Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of Single-Domain Heavy Chain Antibody market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Camelid-Derived
- Shark-Derived
- Fully Human Platform
- Other
- VHH Antibody
- VNAR Antibody
- Human VH Antibody
- Other
- Oncology
- Immunology and Inflammation
- Neurology
- Other
- Pharmaceutical Companies
- Biotechnology Companies
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- MoonLake Immunotherapeutics
- Crescendo Biologics
- Ossianix
- Isogenica
- FairJourney Biologics
- Twist Bioscience
- RayBiotech
- Fortis Life Sciences
- AlpVHHs
- ProteoGenix
- Hybrigenics Services
- Sanyo Fine
- WuXi Biologics
- Harbour BioMed
- Biocytogen
- Sino Biological
- Biointron
- Novamab
- Creative Biolabs
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Single-Domain Heavy Chain Antibody Market Size (2021-2032)
2.1.2 Single-Domain Heavy Chain Antibody Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Single-Domain Heavy Chain Antibody by Country/Region (2021, 2025 & 2032)
2.2 Single-Domain Heavy Chain Antibody Segment by Type
2.2.1 Camelid-Derived
2.2.2 Shark-Derived
2.2.3 Fully Human Platform
2.2.4 Other
2.2.5 Single-Domain Heavy Chain Antibody Market Size by Type
2.2.5.1 Single-Domain Heavy Chain Antibody Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Single-Domain Heavy Chain Antibody Market Size Market Share by Type (2021-2026)
2.3 Single-Domain Heavy Chain Antibody Segment by Antibody Format
2.3.1 VHH Antibody
2.3.2 VNAR Antibody
2.3.3 Human VH Antibody
2.3.4 Other
2.3.5 Single-Domain Heavy Chain Antibody Market Size by Antibody Format
2.3.5.1 Single-Domain Heavy Chain Antibody Market Size CAGR by Antibody Format (2021 VS 2025 VS 2032)
2.3.5.2 Global Single-Domain Heavy Chain Antibody Market Size Market Share by Antibody Format (2021-2026)
2.4 Single-Domain Heavy Chain Antibody Segment by Therapeutic Area
2.4.1 Oncology
2.4.2 Immunology and Inflammation
2.4.3 Neurology
2.4.4 Other
2.4.5 Single-Domain Heavy Chain Antibody Market Size by Therapeutic Area
2.4.5.1 Single-Domain Heavy Chain Antibody Market Size CAGR by Therapeutic Area (2021 VS 2025 VS 2032)
2.4.5.2 Global Single-Domain Heavy Chain Antibody Market Size Market Share by Therapeutic Area (2021-2026)
2.5 Single-Domain Heavy Chain Antibody Segment by Application
2.5.1 Pharmaceutical Companies
2.5.2 Biotechnology Companies
2.5.3 Other
2.5.4 Single-Domain Heavy Chain Antibody Market Size by Application
2.5.4.1 Single-Domain Heavy Chain Antibody Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Single-Domain Heavy Chain Antibody Market Size Market Share by Application (2021-2026)
3 SINGLE-DOMAIN HEAVY CHAIN ANTIBODY MARKET SIZE BY PLAYER
3.1 Single-Domain Heavy Chain Antibody Market Size Market Share by Player
3.1.1 Global Single-Domain Heavy Chain Antibody Revenue by Player (2021-2026)
3.1.2 Global Single-Domain Heavy Chain Antibody Revenue Market Share by Player (2021-2026)
3.2 Global Single-Domain Heavy Chain Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SINGLE-DOMAIN HEAVY CHAIN ANTIBODY BY REGION
4.1 Single-Domain Heavy Chain Antibody Market Size by Region (2021-2026)
4.2 Global Single-Domain Heavy Chain Antibody Annual Revenue by Country/Region (2021-2026)
4.3 Americas Single-Domain Heavy Chain Antibody Market Size Growth (2021-2026)
4.4 APAC Single-Domain Heavy Chain Antibody Market Size Growth (2021-2026)
4.5 Europe Single-Domain Heavy Chain Antibody Market Size Growth (2021-2026)
4.6 Middle East & Africa Single-Domain Heavy Chain Antibody Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Single-Domain Heavy Chain Antibody Market Size by Country (2021-2026)
5.2 Americas Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026)
5.3 Americas Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Single-Domain Heavy Chain Antibody Market Size by Region (2021-2026)
6.2 APAC Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026)
6.3 APAC Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Single-Domain Heavy Chain Antibody Market Size by Country (2021-2026)
7.2 Europe Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026)
7.3 Europe Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Single-Domain Heavy Chain Antibody by Region (2021-2026)
8.2 Middle East & Africa Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026)
8.3 Middle East & Africa Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SINGLE-DOMAIN HEAVY CHAIN ANTIBODY MARKET FORECAST
10.1 Global Single-Domain Heavy Chain Antibody Forecast by Region (2027-2032)
10.1.1 Global Single-Domain Heavy Chain Antibody Forecast by Region (2027-2032)
10.1.2 Americas Single-Domain Heavy Chain Antibody Forecast
10.1.3 APAC Single-Domain Heavy Chain Antibody Forecast
10.1.4 Europe Single-Domain Heavy Chain Antibody Forecast
10.1.5 Middle East & Africa Single-Domain Heavy Chain Antibody Forecast
10.2 Americas Single-Domain Heavy Chain Antibody Forecast by Country (2027-2032)
10.2.1 United States Market Single-Domain Heavy Chain Antibody Forecast
10.2.2 Canada Market Single-Domain Heavy Chain Antibody Forecast
10.2.3 Mexico Market Single-Domain Heavy Chain Antibody Forecast
10.2.4 Brazil Market Single-Domain Heavy Chain Antibody Forecast
10.3 APAC Single-Domain Heavy Chain Antibody Forecast by Region (2027-2032)
10.3.1 China Single-Domain Heavy Chain Antibody Market Forecast
10.3.2 Japan Market Single-Domain Heavy Chain Antibody Forecast
10.3.3 Korea Market Single-Domain Heavy Chain Antibody Forecast
10.3.4 Southeast Asia Market Single-Domain Heavy Chain Antibody Forecast
10.3.5 India Market Single-Domain Heavy Chain Antibody Forecast
10.3.6 Australia Market Single-Domain Heavy Chain Antibody Forecast
10.4 Europe Single-Domain Heavy Chain Antibody Forecast by Country (2027-2032)
10.4.1 Germany Market Single-Domain Heavy Chain Antibody Forecast
10.4.2 France Market Single-Domain Heavy Chain Antibody Forecast
10.4.3 UK Market Single-Domain Heavy Chain Antibody Forecast
10.4.4 Italy Market Single-Domain Heavy Chain Antibody Forecast
10.4.5 Russia Market Single-Domain Heavy Chain Antibody Forecast
10.5 Middle East & Africa Single-Domain Heavy Chain Antibody Forecast by Region (2027-2032)
10.5.1 Egypt Market Single-Domain Heavy Chain Antibody Forecast
10.5.2 South Africa Market Single-Domain Heavy Chain Antibody Forecast
10.5.3 Israel Market Single-Domain Heavy Chain Antibody Forecast
10.5.4 Turkey Market Single-Domain Heavy Chain Antibody Forecast
10.6 Global Single-Domain Heavy Chain Antibody Forecast by Type (2027-2032)
10.7 Global Single-Domain Heavy Chain Antibody Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Single-Domain Heavy Chain Antibody Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Single-Domain Heavy Chain Antibody Product Offered
11.1.3 Sanofi Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 MoonLake Immunotherapeutics
11.2.1 MoonLake Immunotherapeutics Company Information
11.2.2 MoonLake Immunotherapeutics Single-Domain Heavy Chain Antibody Product Offered
11.2.3 MoonLake Immunotherapeutics Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 MoonLake Immunotherapeutics Main Business Overview
11.2.5 MoonLake Immunotherapeutics Latest Developments
11.3 Crescendo Biologics
11.3.1 Crescendo Biologics Company Information
11.3.2 Crescendo Biologics Single-Domain Heavy Chain Antibody Product Offered
11.3.3 Crescendo Biologics Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Crescendo Biologics Main Business Overview
11.3.5 Crescendo Biologics Latest Developments
11.4 Ossianix
11.4.1 Ossianix Company Information
11.4.2 Ossianix Single-Domain Heavy Chain Antibody Product Offered
11.4.3 Ossianix Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Ossianix Main Business Overview
11.4.5 Ossianix Latest Developments
11.5 Isogenica
11.5.1 Isogenica Company Information
11.5.2 Isogenica Single-Domain Heavy Chain Antibody Product Offered
11.5.3 Isogenica Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Isogenica Main Business Overview
11.5.5 Isogenica Latest Developments
11.6 FairJourney Biologics
11.6.1 FairJourney Biologics Company Information
11.6.2 FairJourney Biologics Single-Domain Heavy Chain Antibody Product Offered
11.6.3 FairJourney Biologics Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 FairJourney Biologics Main Business Overview
11.6.5 FairJourney Biologics Latest Developments
11.7 Twist Bioscience
11.7.1 Twist Bioscience Company Information
11.7.2 Twist Bioscience Single-Domain Heavy Chain Antibody Product Offered
11.7.3 Twist Bioscience Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Twist Bioscience Main Business Overview
11.7.5 Twist Bioscience Latest Developments
11.8 RayBiotech
11.8.1 RayBiotech Company Information
11.8.2 RayBiotech Single-Domain Heavy Chain Antibody Product Offered
11.8.3 RayBiotech Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 RayBiotech Main Business Overview
11.8.5 RayBiotech Latest Developments
11.9 Fortis Life Sciences
11.9.1 Fortis Life Sciences Company Information
11.9.2 Fortis Life Sciences Single-Domain Heavy Chain Antibody Product Offered
11.9.3 Fortis Life Sciences Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Fortis Life Sciences Main Business Overview
11.9.5 Fortis Life Sciences Latest Developments
11.10 AlpVHHs
11.10.1 AlpVHHs Company Information
11.10.2 AlpVHHs Single-Domain Heavy Chain Antibody Product Offered
11.10.3 AlpVHHs Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 AlpVHHs Main Business Overview
11.10.5 AlpVHHs Latest Developments
11.11 ProteoGenix
11.11.1 ProteoGenix Company Information
11.11.2 ProteoGenix Single-Domain Heavy Chain Antibody Product Offered
11.11.3 ProteoGenix Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 ProteoGenix Main Business Overview
11.11.5 ProteoGenix Latest Developments
11.12 Hybrigenics Services
11.12.1 Hybrigenics Services Company Information
11.12.2 Hybrigenics Services Single-Domain Heavy Chain Antibody Product Offered
11.12.3 Hybrigenics Services Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Hybrigenics Services Main Business Overview
11.12.5 Hybrigenics Services Latest Developments
11.13 Sanyo Fine
11.13.1 Sanyo Fine Company Information
11.13.2 Sanyo Fine Single-Domain Heavy Chain Antibody Product Offered
11.13.3 Sanyo Fine Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Sanyo Fine Main Business Overview
11.13.5 Sanyo Fine Latest Developments
11.14 WuXi Biologics
11.14.1 WuXi Biologics Company Information
11.14.2 WuXi Biologics Single-Domain Heavy Chain Antibody Product Offered
11.14.3 WuXi Biologics Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 WuXi Biologics Main Business Overview
11.14.5 WuXi Biologics Latest Developments
11.15 Harbour BioMed
11.15.1 Harbour BioMed Company Information
11.15.2 Harbour BioMed Single-Domain Heavy Chain Antibody Product Offered
11.15.3 Harbour BioMed Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Harbour BioMed Main Business Overview
11.15.5 Harbour BioMed Latest Developments
11.16 Biocytogen
11.16.1 Biocytogen Company Information
11.16.2 Biocytogen Single-Domain Heavy Chain Antibody Product Offered
11.16.3 Biocytogen Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Biocytogen Main Business Overview
11.16.5 Biocytogen Latest Developments
11.17 Sino Biological
11.17.1 Sino Biological Company Information
11.17.2 Sino Biological Single-Domain Heavy Chain Antibody Product Offered
11.17.3 Sino Biological Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Sino Biological Main Business Overview
11.17.5 Sino Biological Latest Developments
11.18 Biointron
11.18.1 Biointron Company Information
11.18.2 Biointron Single-Domain Heavy Chain Antibody Product Offered
11.18.3 Biointron Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Biointron Main Business Overview
11.18.5 Biointron Latest Developments
11.19 Novamab
11.19.1 Novamab Company Information
11.19.2 Novamab Single-Domain Heavy Chain Antibody Product Offered
11.19.3 Novamab Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Novamab Main Business Overview
11.19.5 Novamab Latest Developments
11.20 Creative Biolabs
11.20.1 Creative Biolabs Company Information
11.20.2 Creative Biolabs Single-Domain Heavy Chain Antibody Product Offered
11.20.3 Creative Biolabs Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Creative Biolabs Main Business Overview
11.20.5 Creative Biolabs Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Single-Domain Heavy Chain Antibody Market Size (2021-2032)
2.1.2 Single-Domain Heavy Chain Antibody Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Single-Domain Heavy Chain Antibody by Country/Region (2021, 2025 & 2032)
2.2 Single-Domain Heavy Chain Antibody Segment by Type
2.2.1 Camelid-Derived
2.2.2 Shark-Derived
2.2.3 Fully Human Platform
2.2.4 Other
2.2.5 Single-Domain Heavy Chain Antibody Market Size by Type
2.2.5.1 Single-Domain Heavy Chain Antibody Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Single-Domain Heavy Chain Antibody Market Size Market Share by Type (2021-2026)
2.3 Single-Domain Heavy Chain Antibody Segment by Antibody Format
2.3.1 VHH Antibody
2.3.2 VNAR Antibody
2.3.3 Human VH Antibody
2.3.4 Other
2.3.5 Single-Domain Heavy Chain Antibody Market Size by Antibody Format
2.3.5.1 Single-Domain Heavy Chain Antibody Market Size CAGR by Antibody Format (2021 VS 2025 VS 2032)
2.3.5.2 Global Single-Domain Heavy Chain Antibody Market Size Market Share by Antibody Format (2021-2026)
2.4 Single-Domain Heavy Chain Antibody Segment by Therapeutic Area
2.4.1 Oncology
2.4.2 Immunology and Inflammation
2.4.3 Neurology
2.4.4 Other
2.4.5 Single-Domain Heavy Chain Antibody Market Size by Therapeutic Area
2.4.5.1 Single-Domain Heavy Chain Antibody Market Size CAGR by Therapeutic Area (2021 VS 2025 VS 2032)
2.4.5.2 Global Single-Domain Heavy Chain Antibody Market Size Market Share by Therapeutic Area (2021-2026)
2.5 Single-Domain Heavy Chain Antibody Segment by Application
2.5.1 Pharmaceutical Companies
2.5.2 Biotechnology Companies
2.5.3 Other
2.5.4 Single-Domain Heavy Chain Antibody Market Size by Application
2.5.4.1 Single-Domain Heavy Chain Antibody Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Single-Domain Heavy Chain Antibody Market Size Market Share by Application (2021-2026)
3 SINGLE-DOMAIN HEAVY CHAIN ANTIBODY MARKET SIZE BY PLAYER
3.1 Single-Domain Heavy Chain Antibody Market Size Market Share by Player
3.1.1 Global Single-Domain Heavy Chain Antibody Revenue by Player (2021-2026)
3.1.2 Global Single-Domain Heavy Chain Antibody Revenue Market Share by Player (2021-2026)
3.2 Global Single-Domain Heavy Chain Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SINGLE-DOMAIN HEAVY CHAIN ANTIBODY BY REGION
4.1 Single-Domain Heavy Chain Antibody Market Size by Region (2021-2026)
4.2 Global Single-Domain Heavy Chain Antibody Annual Revenue by Country/Region (2021-2026)
4.3 Americas Single-Domain Heavy Chain Antibody Market Size Growth (2021-2026)
4.4 APAC Single-Domain Heavy Chain Antibody Market Size Growth (2021-2026)
4.5 Europe Single-Domain Heavy Chain Antibody Market Size Growth (2021-2026)
4.6 Middle East & Africa Single-Domain Heavy Chain Antibody Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Single-Domain Heavy Chain Antibody Market Size by Country (2021-2026)
5.2 Americas Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026)
5.3 Americas Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Single-Domain Heavy Chain Antibody Market Size by Region (2021-2026)
6.2 APAC Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026)
6.3 APAC Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Single-Domain Heavy Chain Antibody Market Size by Country (2021-2026)
7.2 Europe Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026)
7.3 Europe Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Single-Domain Heavy Chain Antibody by Region (2021-2026)
8.2 Middle East & Africa Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026)
8.3 Middle East & Africa Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SINGLE-DOMAIN HEAVY CHAIN ANTIBODY MARKET FORECAST
10.1 Global Single-Domain Heavy Chain Antibody Forecast by Region (2027-2032)
10.1.1 Global Single-Domain Heavy Chain Antibody Forecast by Region (2027-2032)
10.1.2 Americas Single-Domain Heavy Chain Antibody Forecast
10.1.3 APAC Single-Domain Heavy Chain Antibody Forecast
10.1.4 Europe Single-Domain Heavy Chain Antibody Forecast
10.1.5 Middle East & Africa Single-Domain Heavy Chain Antibody Forecast
10.2 Americas Single-Domain Heavy Chain Antibody Forecast by Country (2027-2032)
10.2.1 United States Market Single-Domain Heavy Chain Antibody Forecast
10.2.2 Canada Market Single-Domain Heavy Chain Antibody Forecast
10.2.3 Mexico Market Single-Domain Heavy Chain Antibody Forecast
10.2.4 Brazil Market Single-Domain Heavy Chain Antibody Forecast
10.3 APAC Single-Domain Heavy Chain Antibody Forecast by Region (2027-2032)
10.3.1 China Single-Domain Heavy Chain Antibody Market Forecast
10.3.2 Japan Market Single-Domain Heavy Chain Antibody Forecast
10.3.3 Korea Market Single-Domain Heavy Chain Antibody Forecast
10.3.4 Southeast Asia Market Single-Domain Heavy Chain Antibody Forecast
10.3.5 India Market Single-Domain Heavy Chain Antibody Forecast
10.3.6 Australia Market Single-Domain Heavy Chain Antibody Forecast
10.4 Europe Single-Domain Heavy Chain Antibody Forecast by Country (2027-2032)
10.4.1 Germany Market Single-Domain Heavy Chain Antibody Forecast
10.4.2 France Market Single-Domain Heavy Chain Antibody Forecast
10.4.3 UK Market Single-Domain Heavy Chain Antibody Forecast
10.4.4 Italy Market Single-Domain Heavy Chain Antibody Forecast
10.4.5 Russia Market Single-Domain Heavy Chain Antibody Forecast
10.5 Middle East & Africa Single-Domain Heavy Chain Antibody Forecast by Region (2027-2032)
10.5.1 Egypt Market Single-Domain Heavy Chain Antibody Forecast
10.5.2 South Africa Market Single-Domain Heavy Chain Antibody Forecast
10.5.3 Israel Market Single-Domain Heavy Chain Antibody Forecast
10.5.4 Turkey Market Single-Domain Heavy Chain Antibody Forecast
10.6 Global Single-Domain Heavy Chain Antibody Forecast by Type (2027-2032)
10.7 Global Single-Domain Heavy Chain Antibody Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Single-Domain Heavy Chain Antibody Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Single-Domain Heavy Chain Antibody Product Offered
11.1.3 Sanofi Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 MoonLake Immunotherapeutics
11.2.1 MoonLake Immunotherapeutics Company Information
11.2.2 MoonLake Immunotherapeutics Single-Domain Heavy Chain Antibody Product Offered
11.2.3 MoonLake Immunotherapeutics Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 MoonLake Immunotherapeutics Main Business Overview
11.2.5 MoonLake Immunotherapeutics Latest Developments
11.3 Crescendo Biologics
11.3.1 Crescendo Biologics Company Information
11.3.2 Crescendo Biologics Single-Domain Heavy Chain Antibody Product Offered
11.3.3 Crescendo Biologics Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Crescendo Biologics Main Business Overview
11.3.5 Crescendo Biologics Latest Developments
11.4 Ossianix
11.4.1 Ossianix Company Information
11.4.2 Ossianix Single-Domain Heavy Chain Antibody Product Offered
11.4.3 Ossianix Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Ossianix Main Business Overview
11.4.5 Ossianix Latest Developments
11.5 Isogenica
11.5.1 Isogenica Company Information
11.5.2 Isogenica Single-Domain Heavy Chain Antibody Product Offered
11.5.3 Isogenica Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Isogenica Main Business Overview
11.5.5 Isogenica Latest Developments
11.6 FairJourney Biologics
11.6.1 FairJourney Biologics Company Information
11.6.2 FairJourney Biologics Single-Domain Heavy Chain Antibody Product Offered
11.6.3 FairJourney Biologics Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 FairJourney Biologics Main Business Overview
11.6.5 FairJourney Biologics Latest Developments
11.7 Twist Bioscience
11.7.1 Twist Bioscience Company Information
11.7.2 Twist Bioscience Single-Domain Heavy Chain Antibody Product Offered
11.7.3 Twist Bioscience Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Twist Bioscience Main Business Overview
11.7.5 Twist Bioscience Latest Developments
11.8 RayBiotech
11.8.1 RayBiotech Company Information
11.8.2 RayBiotech Single-Domain Heavy Chain Antibody Product Offered
11.8.3 RayBiotech Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 RayBiotech Main Business Overview
11.8.5 RayBiotech Latest Developments
11.9 Fortis Life Sciences
11.9.1 Fortis Life Sciences Company Information
11.9.2 Fortis Life Sciences Single-Domain Heavy Chain Antibody Product Offered
11.9.3 Fortis Life Sciences Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Fortis Life Sciences Main Business Overview
11.9.5 Fortis Life Sciences Latest Developments
11.10 AlpVHHs
11.10.1 AlpVHHs Company Information
11.10.2 AlpVHHs Single-Domain Heavy Chain Antibody Product Offered
11.10.3 AlpVHHs Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 AlpVHHs Main Business Overview
11.10.5 AlpVHHs Latest Developments
11.11 ProteoGenix
11.11.1 ProteoGenix Company Information
11.11.2 ProteoGenix Single-Domain Heavy Chain Antibody Product Offered
11.11.3 ProteoGenix Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 ProteoGenix Main Business Overview
11.11.5 ProteoGenix Latest Developments
11.12 Hybrigenics Services
11.12.1 Hybrigenics Services Company Information
11.12.2 Hybrigenics Services Single-Domain Heavy Chain Antibody Product Offered
11.12.3 Hybrigenics Services Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Hybrigenics Services Main Business Overview
11.12.5 Hybrigenics Services Latest Developments
11.13 Sanyo Fine
11.13.1 Sanyo Fine Company Information
11.13.2 Sanyo Fine Single-Domain Heavy Chain Antibody Product Offered
11.13.3 Sanyo Fine Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Sanyo Fine Main Business Overview
11.13.5 Sanyo Fine Latest Developments
11.14 WuXi Biologics
11.14.1 WuXi Biologics Company Information
11.14.2 WuXi Biologics Single-Domain Heavy Chain Antibody Product Offered
11.14.3 WuXi Biologics Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 WuXi Biologics Main Business Overview
11.14.5 WuXi Biologics Latest Developments
11.15 Harbour BioMed
11.15.1 Harbour BioMed Company Information
11.15.2 Harbour BioMed Single-Domain Heavy Chain Antibody Product Offered
11.15.3 Harbour BioMed Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Harbour BioMed Main Business Overview
11.15.5 Harbour BioMed Latest Developments
11.16 Biocytogen
11.16.1 Biocytogen Company Information
11.16.2 Biocytogen Single-Domain Heavy Chain Antibody Product Offered
11.16.3 Biocytogen Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Biocytogen Main Business Overview
11.16.5 Biocytogen Latest Developments
11.17 Sino Biological
11.17.1 Sino Biological Company Information
11.17.2 Sino Biological Single-Domain Heavy Chain Antibody Product Offered
11.17.3 Sino Biological Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Sino Biological Main Business Overview
11.17.5 Sino Biological Latest Developments
11.18 Biointron
11.18.1 Biointron Company Information
11.18.2 Biointron Single-Domain Heavy Chain Antibody Product Offered
11.18.3 Biointron Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Biointron Main Business Overview
11.18.5 Biointron Latest Developments
11.19 Novamab
11.19.1 Novamab Company Information
11.19.2 Novamab Single-Domain Heavy Chain Antibody Product Offered
11.19.3 Novamab Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Novamab Main Business Overview
11.19.5 Novamab Latest Developments
11.20 Creative Biolabs
11.20.1 Creative Biolabs Company Information
11.20.2 Creative Biolabs Single-Domain Heavy Chain Antibody Product Offered
11.20.3 Creative Biolabs Single-Domain Heavy Chain Antibody Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Creative Biolabs Main Business Overview
11.20.5 Creative Biolabs Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Single-Domain Heavy Chain Antibody Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Single-Domain Heavy Chain Antibody Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Camelid-Derived
Table 4. Major Players of Shark-Derived
Table 5. Major Players of Fully Human Platform
Table 6. Major Players of Other
Table 7. Single-Domain Heavy Chain Antibody Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Type (2021-2026)
Table 10. Major Players of VHH Antibody
Table 11. Major Players of VNAR Antibody
Table 12. Major Players of Human VH Antibody
Table 13. Major Players of Other
Table 14. Single-Domain Heavy Chain Antibody Market Size CAGR by Antibody Format (2021 VS 2025 VS 2032) & ($ millions)
Table 15. Global Single-Domain Heavy Chain Antibody Market Size by Antibody Format (2021-2026) & ($ millions)
Table 16. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Antibody Format (2021-2026)
Table 17. Major Players of Oncology
Table 18. Major Players of Immunology and Inflammation
Table 19. Major Players of Neurology
Table 20. Major Players of Other
Table 21. Single-Domain Heavy Chain Antibody Market Size CAGR by Therapeutic Area (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Single-Domain Heavy Chain Antibody Market Size by Therapeutic Area (2021-2026) & ($ millions)
Table 23. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Therapeutic Area (2021-2026)
Table 24. Single-Domain Heavy Chain Antibody Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026) & ($ millions)
Table 26. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Application (2021-2026)
Table 27. Global Single-Domain Heavy Chain Antibody Revenue by Player (2021-2026) & ($ millions)
Table 28. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Player (2021-2026)
Table 29. Single-Domain Heavy Chain Antibody Key Players Head office and Products Offered
Table 30. Single-Domain Heavy Chain Antibody Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global Single-Domain Heavy Chain Antibody Market Size by Region (2021-2026) & ($ millions)
Table 34. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Region (2021-2026)
Table 35. Global Single-Domain Heavy Chain Antibody Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Single-Domain Heavy Chain Antibody Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas Single-Domain Heavy Chain Antibody Market Size Market Share by Country (2021-2026)
Table 39. Americas Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026) & ($ millions)
Table 40. Americas Single-Domain Heavy Chain Antibody Market Size Market Share by Type (2021-2026)
Table 41. Americas Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026) & ($ millions)
Table 42. Americas Single-Domain Heavy Chain Antibody Market Size Market Share by Application (2021-2026)
Table 43. APAC Single-Domain Heavy Chain Antibody Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC Single-Domain Heavy Chain Antibody Market Size Market Share by Region (2021-2026)
Table 45. APAC Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026) & ($ millions)
Table 46. APAC Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026) & ($ millions)
Table 47. Europe Single-Domain Heavy Chain Antibody Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe Single-Domain Heavy Chain Antibody Market Size Market Share by Country (2021-2026)
Table 49. Europe Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026) & ($ millions)
Table 50. Europe Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026) & ($ millions)
Table 51. Middle East & Africa Single-Domain Heavy Chain Antibody Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of Single-Domain Heavy Chain Antibody
Table 55. Key Market Challenges & Risks of Single-Domain Heavy Chain Antibody
Table 56. Key Industry Trends of Single-Domain Heavy Chain Antibody
Table 57. Global Single-Domain Heavy Chain Antibody Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global Single-Domain Heavy Chain Antibody Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global Single-Domain Heavy Chain Antibody Market Size Forecast by Type (2027-2032) & ($ millions)
Table 60. Global Single-Domain Heavy Chain Antibody Market Size Forecast by Application (2027-2032) & ($ millions)
Table 61. Sanofi Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 62. Sanofi Single-Domain Heavy Chain Antibody Product Offered
Table 63. Sanofi Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Sanofi Main Business
Table 65. Sanofi Latest Developments
Table 66. MoonLake Immunotherapeutics Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 67. MoonLake Immunotherapeutics Single-Domain Heavy Chain Antibody Product Offered
Table 68. MoonLake Immunotherapeutics Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. MoonLake Immunotherapeutics Main Business
Table 70. MoonLake Immunotherapeutics Latest Developments
Table 71. Crescendo Biologics Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 72. Crescendo Biologics Single-Domain Heavy Chain Antibody Product Offered
Table 73. Crescendo Biologics Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Crescendo Biologics Main Business
Table 75. Crescendo Biologics Latest Developments
Table 76. Ossianix Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 77. Ossianix Single-Domain Heavy Chain Antibody Product Offered
Table 78. Ossianix Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Ossianix Main Business
Table 80. Ossianix Latest Developments
Table 81. Isogenica Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 82. Isogenica Single-Domain Heavy Chain Antibody Product Offered
Table 83. Isogenica Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Isogenica Main Business
Table 85. Isogenica Latest Developments
Table 86. FairJourney Biologics Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 87. FairJourney Biologics Single-Domain Heavy Chain Antibody Product Offered
Table 88. FairJourney Biologics Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. FairJourney Biologics Main Business
Table 90. FairJourney Biologics Latest Developments
Table 91. Twist Bioscience Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 92. Twist Bioscience Single-Domain Heavy Chain Antibody Product Offered
Table 93. Twist Bioscience Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Twist Bioscience Main Business
Table 95. Twist Bioscience Latest Developments
Table 96. RayBiotech Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 97. RayBiotech Single-Domain Heavy Chain Antibody Product Offered
Table 98. RayBiotech Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. RayBiotech Main Business
Table 100. RayBiotech Latest Developments
Table 101. Fortis Life Sciences Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 102. Fortis Life Sciences Single-Domain Heavy Chain Antibody Product Offered
Table 103. Fortis Life Sciences Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Fortis Life Sciences Main Business
Table 105. Fortis Life Sciences Latest Developments
Table 106. AlpVHHs Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 107. AlpVHHs Single-Domain Heavy Chain Antibody Product Offered
Table 108. AlpVHHs Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. AlpVHHs Main Business
Table 110. AlpVHHs Latest Developments
Table 111. ProteoGenix Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 112. ProteoGenix Single-Domain Heavy Chain Antibody Product Offered
Table 113. ProteoGenix Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. ProteoGenix Main Business
Table 115. ProteoGenix Latest Developments
Table 116. Hybrigenics Services Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 117. Hybrigenics Services Single-Domain Heavy Chain Antibody Product Offered
Table 118. Hybrigenics Services Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Hybrigenics Services Main Business
Table 120. Hybrigenics Services Latest Developments
Table 121. Sanyo Fine Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 122. Sanyo Fine Single-Domain Heavy Chain Antibody Product Offered
Table 123. Sanyo Fine Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Sanyo Fine Main Business
Table 125. Sanyo Fine Latest Developments
Table 126. WuXi Biologics Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 127. WuXi Biologics Single-Domain Heavy Chain Antibody Product Offered
Table 128. WuXi Biologics Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. WuXi Biologics Main Business
Table 130. WuXi Biologics Latest Developments
Table 131. Harbour BioMed Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 132. Harbour BioMed Single-Domain Heavy Chain Antibody Product Offered
Table 133. Harbour BioMed Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Harbour BioMed Main Business
Table 135. Harbour BioMed Latest Developments
Table 136. Biocytogen Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 137. Biocytogen Single-Domain Heavy Chain Antibody Product Offered
Table 138. Biocytogen Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Biocytogen Main Business
Table 140. Biocytogen Latest Developments
Table 141. Sino Biological Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 142. Sino Biological Single-Domain Heavy Chain Antibody Product Offered
Table 143. Sino Biological Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Sino Biological Main Business
Table 145. Sino Biological Latest Developments
Table 146. Biointron Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 147. Biointron Single-Domain Heavy Chain Antibody Product Offered
Table 148. Biointron Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. Biointron Main Business
Table 150. Biointron Latest Developments
Table 151. Novamab Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 152. Novamab Single-Domain Heavy Chain Antibody Product Offered
Table 153. Novamab Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 154. Novamab Main Business
Table 155. Novamab Latest Developments
Table 156. Creative Biolabs Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 157. Creative Biolabs Single-Domain Heavy Chain Antibody Product Offered
Table 158. Creative Biolabs Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 159. Creative Biolabs Main Business
Table 160. Creative Biolabs Latest Developments
Table 1. Single-Domain Heavy Chain Antibody Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Single-Domain Heavy Chain Antibody Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Camelid-Derived
Table 4. Major Players of Shark-Derived
Table 5. Major Players of Fully Human Platform
Table 6. Major Players of Other
Table 7. Single-Domain Heavy Chain Antibody Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Type (2021-2026)
Table 10. Major Players of VHH Antibody
Table 11. Major Players of VNAR Antibody
Table 12. Major Players of Human VH Antibody
Table 13. Major Players of Other
Table 14. Single-Domain Heavy Chain Antibody Market Size CAGR by Antibody Format (2021 VS 2025 VS 2032) & ($ millions)
Table 15. Global Single-Domain Heavy Chain Antibody Market Size by Antibody Format (2021-2026) & ($ millions)
Table 16. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Antibody Format (2021-2026)
Table 17. Major Players of Oncology
Table 18. Major Players of Immunology and Inflammation
Table 19. Major Players of Neurology
Table 20. Major Players of Other
Table 21. Single-Domain Heavy Chain Antibody Market Size CAGR by Therapeutic Area (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Single-Domain Heavy Chain Antibody Market Size by Therapeutic Area (2021-2026) & ($ millions)
Table 23. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Therapeutic Area (2021-2026)
Table 24. Single-Domain Heavy Chain Antibody Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026) & ($ millions)
Table 26. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Application (2021-2026)
Table 27. Global Single-Domain Heavy Chain Antibody Revenue by Player (2021-2026) & ($ millions)
Table 28. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Player (2021-2026)
Table 29. Single-Domain Heavy Chain Antibody Key Players Head office and Products Offered
Table 30. Single-Domain Heavy Chain Antibody Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 31. New Products and Potential Entrants
Table 32. Mergers & Acquisitions, Expansion
Table 33. Global Single-Domain Heavy Chain Antibody Market Size by Region (2021-2026) & ($ millions)
Table 34. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Region (2021-2026)
Table 35. Global Single-Domain Heavy Chain Antibody Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Single-Domain Heavy Chain Antibody Market Size by Country (2021-2026) & ($ millions)
Table 38. Americas Single-Domain Heavy Chain Antibody Market Size Market Share by Country (2021-2026)
Table 39. Americas Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026) & ($ millions)
Table 40. Americas Single-Domain Heavy Chain Antibody Market Size Market Share by Type (2021-2026)
Table 41. Americas Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026) & ($ millions)
Table 42. Americas Single-Domain Heavy Chain Antibody Market Size Market Share by Application (2021-2026)
Table 43. APAC Single-Domain Heavy Chain Antibody Market Size by Region (2021-2026) & ($ millions)
Table 44. APAC Single-Domain Heavy Chain Antibody Market Size Market Share by Region (2021-2026)
Table 45. APAC Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026) & ($ millions)
Table 46. APAC Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026) & ($ millions)
Table 47. Europe Single-Domain Heavy Chain Antibody Market Size by Country (2021-2026) & ($ millions)
Table 48. Europe Single-Domain Heavy Chain Antibody Market Size Market Share by Country (2021-2026)
Table 49. Europe Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026) & ($ millions)
Table 50. Europe Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026) & ($ millions)
Table 51. Middle East & Africa Single-Domain Heavy Chain Antibody Market Size by Region (2021-2026) & ($ millions)
Table 52. Middle East & Africa Single-Domain Heavy Chain Antibody Market Size by Type (2021-2026) & ($ millions)
Table 53. Middle East & Africa Single-Domain Heavy Chain Antibody Market Size by Application (2021-2026) & ($ millions)
Table 54. Key Market Drivers & Growth Opportunities of Single-Domain Heavy Chain Antibody
Table 55. Key Market Challenges & Risks of Single-Domain Heavy Chain Antibody
Table 56. Key Industry Trends of Single-Domain Heavy Chain Antibody
Table 57. Global Single-Domain Heavy Chain Antibody Market Size Forecast by Region (2027-2032) & ($ millions)
Table 58. Global Single-Domain Heavy Chain Antibody Market Size Market Share Forecast by Region (2027-2032)
Table 59. Global Single-Domain Heavy Chain Antibody Market Size Forecast by Type (2027-2032) & ($ millions)
Table 60. Global Single-Domain Heavy Chain Antibody Market Size Forecast by Application (2027-2032) & ($ millions)
Table 61. Sanofi Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 62. Sanofi Single-Domain Heavy Chain Antibody Product Offered
Table 63. Sanofi Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Sanofi Main Business
Table 65. Sanofi Latest Developments
Table 66. MoonLake Immunotherapeutics Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 67. MoonLake Immunotherapeutics Single-Domain Heavy Chain Antibody Product Offered
Table 68. MoonLake Immunotherapeutics Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. MoonLake Immunotherapeutics Main Business
Table 70. MoonLake Immunotherapeutics Latest Developments
Table 71. Crescendo Biologics Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 72. Crescendo Biologics Single-Domain Heavy Chain Antibody Product Offered
Table 73. Crescendo Biologics Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Crescendo Biologics Main Business
Table 75. Crescendo Biologics Latest Developments
Table 76. Ossianix Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 77. Ossianix Single-Domain Heavy Chain Antibody Product Offered
Table 78. Ossianix Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Ossianix Main Business
Table 80. Ossianix Latest Developments
Table 81. Isogenica Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 82. Isogenica Single-Domain Heavy Chain Antibody Product Offered
Table 83. Isogenica Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Isogenica Main Business
Table 85. Isogenica Latest Developments
Table 86. FairJourney Biologics Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 87. FairJourney Biologics Single-Domain Heavy Chain Antibody Product Offered
Table 88. FairJourney Biologics Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. FairJourney Biologics Main Business
Table 90. FairJourney Biologics Latest Developments
Table 91. Twist Bioscience Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 92. Twist Bioscience Single-Domain Heavy Chain Antibody Product Offered
Table 93. Twist Bioscience Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Twist Bioscience Main Business
Table 95. Twist Bioscience Latest Developments
Table 96. RayBiotech Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 97. RayBiotech Single-Domain Heavy Chain Antibody Product Offered
Table 98. RayBiotech Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. RayBiotech Main Business
Table 100. RayBiotech Latest Developments
Table 101. Fortis Life Sciences Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 102. Fortis Life Sciences Single-Domain Heavy Chain Antibody Product Offered
Table 103. Fortis Life Sciences Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Fortis Life Sciences Main Business
Table 105. Fortis Life Sciences Latest Developments
Table 106. AlpVHHs Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 107. AlpVHHs Single-Domain Heavy Chain Antibody Product Offered
Table 108. AlpVHHs Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. AlpVHHs Main Business
Table 110. AlpVHHs Latest Developments
Table 111. ProteoGenix Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 112. ProteoGenix Single-Domain Heavy Chain Antibody Product Offered
Table 113. ProteoGenix Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. ProteoGenix Main Business
Table 115. ProteoGenix Latest Developments
Table 116. Hybrigenics Services Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 117. Hybrigenics Services Single-Domain Heavy Chain Antibody Product Offered
Table 118. Hybrigenics Services Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Hybrigenics Services Main Business
Table 120. Hybrigenics Services Latest Developments
Table 121. Sanyo Fine Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 122. Sanyo Fine Single-Domain Heavy Chain Antibody Product Offered
Table 123. Sanyo Fine Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Sanyo Fine Main Business
Table 125. Sanyo Fine Latest Developments
Table 126. WuXi Biologics Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 127. WuXi Biologics Single-Domain Heavy Chain Antibody Product Offered
Table 128. WuXi Biologics Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. WuXi Biologics Main Business
Table 130. WuXi Biologics Latest Developments
Table 131. Harbour BioMed Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 132. Harbour BioMed Single-Domain Heavy Chain Antibody Product Offered
Table 133. Harbour BioMed Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Harbour BioMed Main Business
Table 135. Harbour BioMed Latest Developments
Table 136. Biocytogen Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 137. Biocytogen Single-Domain Heavy Chain Antibody Product Offered
Table 138. Biocytogen Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Biocytogen Main Business
Table 140. Biocytogen Latest Developments
Table 141. Sino Biological Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 142. Sino Biological Single-Domain Heavy Chain Antibody Product Offered
Table 143. Sino Biological Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Sino Biological Main Business
Table 145. Sino Biological Latest Developments
Table 146. Biointron Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 147. Biointron Single-Domain Heavy Chain Antibody Product Offered
Table 148. Biointron Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. Biointron Main Business
Table 150. Biointron Latest Developments
Table 151. Novamab Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 152. Novamab Single-Domain Heavy Chain Antibody Product Offered
Table 153. Novamab Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 154. Novamab Main Business
Table 155. Novamab Latest Developments
Table 156. Creative Biolabs Details, Company Type, Single-Domain Heavy Chain Antibody Area Served and Its Competitors
Table 157. Creative Biolabs Single-Domain Heavy Chain Antibody Product Offered
Table 158. Creative Biolabs Single-Domain Heavy Chain Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 159. Creative Biolabs Main Business
Table 160. Creative Biolabs Latest Developments
LIST OF FIGURES
Figure 1. Single-Domain Heavy Chain Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Single-Domain Heavy Chain Antibody Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Single-Domain Heavy Chain Antibody Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Single-Domain Heavy Chain Antibody Sales Market Share by Country/Region (2025)
Figure 8. Single-Domain Heavy Chain Antibody Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Type in 2025
Figure 10. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Antibody Format in 2025
Figure 11. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Therapeutic Area in 2025
Figure 12. Single-Domain Heavy Chain Antibody in Pharmaceutical Companies
Figure 13. Global Single-Domain Heavy Chain Antibody Market: Pharmaceutical Companies (2021-2026) & ($ millions)
Figure 14. Single-Domain Heavy Chain Antibody in Biotechnology Companies
Figure 15. Global Single-Domain Heavy Chain Antibody Market: Biotechnology Companies (2021-2026) & ($ millions)
Figure 16. Single-Domain Heavy Chain Antibody in Other
Figure 17. Global Single-Domain Heavy Chain Antibody Market: Other (2021-2026) & ($ millions)
Figure 18. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Application in 2025
Figure 19. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Player in 2025
Figure 20. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Region (2021-2026)
Figure 21. Americas Single-Domain Heavy Chain Antibody Market Size 2021-2026 ($ millions)
Figure 22. APAC Single-Domain Heavy Chain Antibody Market Size 2021-2026 ($ millions)
Figure 23. Europe Single-Domain Heavy Chain Antibody Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Single-Domain Heavy Chain Antibody Market Size 2021-2026 ($ millions)
Figure 25. Americas Single-Domain Heavy Chain Antibody Value Market Share by Country in 2025
Figure 26. United States Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Single-Domain Heavy Chain Antibody Market Size Market Share by Region in 2025
Figure 31. APAC Single-Domain Heavy Chain Antibody Market Size Market Share by Type (2021-2026)
Figure 32. APAC Single-Domain Heavy Chain Antibody Market Size Market Share by Application (2021-2026)
Figure 33. China Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 37. India Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Single-Domain Heavy Chain Antibody Market Size Market Share by Country in 2025
Figure 40. Europe Single-Domain Heavy Chain Antibody Market Size Market Share by Type (2021-2026)
Figure 41. Europe Single-Domain Heavy Chain Antibody Market Size Market Share by Application (2021-2026)
Figure 42. Germany Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 43. France Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Single-Domain Heavy Chain Antibody Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Single-Domain Heavy Chain Antibody Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Single-Domain Heavy Chain Antibody Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 56. APAC Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 57. Europe Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 59. United States Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 60. Canada Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 61. Mexico Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 62. Brazil Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 63. China Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 64. Japan Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 65. Korea Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 67. India Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 68. Australia Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 69. Germany Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 70. France Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 71. UK Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 72. Italy Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 73. Russia Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 74. Egypt Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 75. South Africa Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 76. Israel Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 77. Turkey Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 78. Global Single-Domain Heavy Chain Antibody Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Single-Domain Heavy Chain Antibody Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 1. Single-Domain Heavy Chain Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Single-Domain Heavy Chain Antibody Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Single-Domain Heavy Chain Antibody Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Single-Domain Heavy Chain Antibody Sales Market Share by Country/Region (2025)
Figure 8. Single-Domain Heavy Chain Antibody Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Type in 2025
Figure 10. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Antibody Format in 2025
Figure 11. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Therapeutic Area in 2025
Figure 12. Single-Domain Heavy Chain Antibody in Pharmaceutical Companies
Figure 13. Global Single-Domain Heavy Chain Antibody Market: Pharmaceutical Companies (2021-2026) & ($ millions)
Figure 14. Single-Domain Heavy Chain Antibody in Biotechnology Companies
Figure 15. Global Single-Domain Heavy Chain Antibody Market: Biotechnology Companies (2021-2026) & ($ millions)
Figure 16. Single-Domain Heavy Chain Antibody in Other
Figure 17. Global Single-Domain Heavy Chain Antibody Market: Other (2021-2026) & ($ millions)
Figure 18. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Application in 2025
Figure 19. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Player in 2025
Figure 20. Global Single-Domain Heavy Chain Antibody Market Size Market Share by Region (2021-2026)
Figure 21. Americas Single-Domain Heavy Chain Antibody Market Size 2021-2026 ($ millions)
Figure 22. APAC Single-Domain Heavy Chain Antibody Market Size 2021-2026 ($ millions)
Figure 23. Europe Single-Domain Heavy Chain Antibody Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Single-Domain Heavy Chain Antibody Market Size 2021-2026 ($ millions)
Figure 25. Americas Single-Domain Heavy Chain Antibody Value Market Share by Country in 2025
Figure 26. United States Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Single-Domain Heavy Chain Antibody Market Size Market Share by Region in 2025
Figure 31. APAC Single-Domain Heavy Chain Antibody Market Size Market Share by Type (2021-2026)
Figure 32. APAC Single-Domain Heavy Chain Antibody Market Size Market Share by Application (2021-2026)
Figure 33. China Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 37. India Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Single-Domain Heavy Chain Antibody Market Size Market Share by Country in 2025
Figure 40. Europe Single-Domain Heavy Chain Antibody Market Size Market Share by Type (2021-2026)
Figure 41. Europe Single-Domain Heavy Chain Antibody Market Size Market Share by Application (2021-2026)
Figure 42. Germany Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 43. France Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Single-Domain Heavy Chain Antibody Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Single-Domain Heavy Chain Antibody Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Single-Domain Heavy Chain Antibody Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Single-Domain Heavy Chain Antibody Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 56. APAC Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 57. Europe Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 59. United States Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 60. Canada Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 61. Mexico Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 62. Brazil Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 63. China Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 64. Japan Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 65. Korea Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 67. India Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 68. Australia Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 69. Germany Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 70. France Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 71. UK Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 72. Italy Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 73. Russia Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 74. Egypt Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 75. South Africa Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 76. Israel Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 77. Turkey Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
Figure 78. Global Single-Domain Heavy Chain Antibody Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Single-Domain Heavy Chain Antibody Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Single-Domain Heavy Chain Antibody Market Size 2027-2032 ($ millions)
